Merck Sharp & Dohme LLC

Works in Cardiovascular · Dermatology · ENT · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Psychiatry · Renal & urogenital · Respiratory · Women's health

Merck Sharp & Dohme LLC is a clinical trial sponsor. It has 231 active clinical trials with 172,412 planned participants, across 17 therapeutic areas. Since 2021 it has completed 473 trials and stopped 74 early.

Trial track record · since 2021

231Active trials172,412 planned participants
473Completed404 with results posted
74Stopped early14% of finished trials

Pipeline · 231 active trials

StageTrialStatus

On the market

11 approved drug applications with a product on the market.

Questions about Merck Sharp & Dohme LLC

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-06.

Approve Suite is not affiliated with Merck Sharp & Dohme LLC.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.